Literature DB >> 19777325

An N- and C-terminal truncated isoform of zinc finger X-linked duplicated C protein represses MHC class II transcription.

Anastasiia Aleksandrova1, Oleksandr Galkin, Rupa Koneni, Joseph D Fontes.   

Abstract

The zinc finger X-linked duplicated A (ZXDA) and ZXDC proteins are both required for robust transcription of major histocompatibility complex class II (MHC II) genes. Aside from the full length ZXDC mRNA transcript, at least one additional mRNA is produced by the ZXDC gene, in which transcription initiates within the first exon and terminates within the seventh intron. The protein product produced from this transcript, which we have named ZXDC2, is truncated on both the N- and C-terminus. We demonstrate here that ZXDC2 functions to repress MHC II transcription induced in HeLa cells treated with IFN-gamma. We further demonstrate that ZXDC2 interacts with both ZXDA and ZXDC, suggesting a mechanism by which ZXDC2 may inhibit MHC II transcription. These studies not only provide additional support for the role of ZXD proteins in regulating MHC II transcription, but also demonstrate a unique mechanism for the synthesis of a mRNA isoform.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19777325      PMCID: PMC3488874          DOI: 10.1007/s11010-009-0280-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

Review 1.  RNA polymerase II and the integration of nuclear events.

Authors:  Y Hirose; J L Manley
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

2.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

Review 3.  When the lymphocyte loses its clothes.

Authors:  Nada Nekrep; Joseph D Fontes; Matthias Geyer; B Matija Peterlin
Journal:  Immunity       Date:  2003-04       Impact factor: 31.745

Review 4.  Transcriptional regulation of the MHC class II antigen presentation pathway.

Authors:  Jeremy M Boss; Peter E Jensen
Journal:  Curr Opin Immunol       Date:  2003-02       Impact factor: 7.486

Review 5.  On the importance of being co-transcriptional.

Authors:  Karla M Neugebauer
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

Review 6.  Cracking the RNA polymerase II CTD code.

Authors:  Sylvain Egloff; Shona Murphy
Journal:  Trends Genet       Date:  2008-05-03       Impact factor: 11.639

7.  The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes.

Authors:  Rajini Mudhasani; Joseph D Fontes
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets.

Authors:  R S Accolla
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

9.  Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription.

Authors:  R Mantovani; U Pessara; F Tronche; X Y Li; A M Knapp; J L Pasquali; C Benoist; D Mathis
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

10.  Co-evolution from yeast to mouse: cDNA cloning of the two NF-Y (CP-1/CBF) subunits.

Authors:  R Hooft van Huijsduijnen; X Y Li; D Black; H Matthes; C Benoist; D Mathis
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

View more
  3 in total

1.  The zinc finger transcription factor ZXDC activates CCL2 gene expression by opposing BCL6-mediated repression.

Authors:  Jon E Ramsey; Joseph D Fontes
Journal:  Mol Immunol       Date:  2013-08-14       Impact factor: 4.407

2.  FBXO38 Ubiquitin Ligase Controls Centromere Integrity via ZXDA/B Stability.

Authors:  Nikol Dibus; Vladimir Korinek; Lukas Cermak
Journal:  Front Cell Dev Biol       Date:  2022-06-23

3.  FBXO38 Ubiquitin Ligase Controls Sertoli Cell Maturation.

Authors:  Nikol Dibus; Eliska Zobalova; Mario A M Monleon; Vladimir Korinek; Dominik Filipp; Jana Petrusova; Radislav Sedlacek; Petr Kasparek; Lukas Cermak
Journal:  Front Cell Dev Biol       Date:  2022-06-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.